Menu
Not yet recruiting NCT07079917

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

No phase Interventional Alveolar Bone Loss

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: subperiosteal tunneling for horizontal alveolar ridge augmentation, conventional alveolar ridge augmentation.
Who it may be relevant to
Registry conditions: Alveolar Bone Loss. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and Platelet-Rich Fibrin: Randomized Controlled Trial

Overview

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Interventions

  • Procedure subperiosteal tunneling for horizontal alveolar ridge augmentation
    subperiosteal dissection through horizontal incision only
  • Procedure conventional alveolar ridge augmentation
    horizontal alveolar ridge augmentation through trapezoidal flap

Primary outcome measures

  • Maxillary alveolar bone width [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width.
  • Minimum vertical height of 8 mm.
  • Gingival tissue of healthy adequate keratinization, more than 2mm.

Exclusion criteria

  • The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing
  • Radiotherapy to the head and neck region
  • Chemotherapy within the last 12 months
  • Uncontrolled periodontitis
  • Smoking
  • Bisphosphonate therapy
  • Pregnancy
  • Presence of periapical infection or lesion

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Fayoum University — Al Fayyum

Identifiers

NCT: NCT07079917 · will be ready at end of study

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗